Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Reservation Policy & Attendance Limit: This event has an attendance limit of 300 people and seats will be reserved on a first-come, first-served basis. Please be sure to register as soon as possible to reserve your seat and ensure your attendance.
*We strive to be inclusive. All are welcome to attend!